subject: Non-hodgkin's Lymphoma (nhl) - Drug Pipeline Analysis And Market Forecasts To 2015 [print this page] Summary Summary
The industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare industry, Non-Hodgkin's Lymphoma Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global NHL market. The report identifies the key trends shaping and driving the global NHL market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global NHL sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.
Scope
The scope of the report includes:
- Annualized global Non-Hodgkin's Lymphoma (NHL) market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
- Analysis of the current and future market competition in the global NHL market. Key market players covered include Genentech, Inc., GSK, Eli Lilly and Company, Pfizer Inc/ Wyeth, Novartis AG, and Biogen Idec.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with NHL.
